North American Prescription Price Equity Act of 2001 - Amends the Internal Revenue Code to allow drug manufacturers a limited tax credit if they certify that the wholesale price of a drug in the United States market is not greater than its wholesale price in the Canadian or Mexican market.
Actions
Mar 8, 2001
Referred to the House Committee on Ways and Means.
Mar 8, 2001
Sponsor introductory remarks on measure. (CR E317)